Search for: "House v. European Health Spa" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 May 2019, 2:13 pm
Trade marksGuestKat Nedim Malovic takes a look at a decision of EUIPO first Board of Appeal concerning the relevant public’s perception of the polysemic term SPA, which, on the one hand, is the designation of the Belgian town Spa, where there is also a health spa, well-known to the Belgian public; on the other hand, it is also the common name that designates a spa-facility (a hydrotherapy facility). [read post]
4 Jun 2015, 2:25 am
Readers may be getting a slight sense of déjà vu at this point, recalling that another CJEU reference, Case C-351/12 Ochranný svaz autorský pro práva k dílům hudebním, os (OSA) v Léčebné lázně Mariánské Lázně as [noted by Eleonora for the IPKat here], dealt with a similar set of facts involving a health spa. [read post]
4 Jun 2015, 3:56 pm by Jeremy
Readers may be getting a slight sense of déjà vu at this point, recalling that another CJEU reference, Case C-351/12 Ochranný svaz autorský pro práva k dílům hudebním, os (OSA) v Léčebné lázně Mariánské Lázně as [noted by Eleonora for the IPKat here], dealt with a similar set of facts involving a health spa. [read post]
7 Feb 2011, 2:58 am by Marie Louise
Plasticos and Colgate-Palmolive (EPLAW) Elio, Edwin in tug-of-love over FIORUCCI name – Case C-263/09  Edwin v OHIM (IPKat) ONEL edges closer to resolution as Hague Court pops the questions (IPKat) No abuse, no answers: AG gives Budweiser’s dirty tricks a clean bill of health: Bud? [read post]
20 Jul 2009, 2:00 am
(PatLit)   United States US General House approves USPTO funding bill (Managing Intellectual Property) US measures to strengthen trade enforcement (Intellectual Property Watch)   US Patents Peer-to-patent project set on hold. [read post]
16 May 2008, 8:03 am
, 20-21 May: US ACI ‘In-house counsel forum on pharmaceutical antitrust’ – Maryland: (Orange Book Blog), 26-27 May : EU Workshop for mediators in IP disputes – Geneva: (IPR-Helpdesk), 27 May: Oliver Rivers to give short talk on ‘spurious precision’ – London: (IP finance), 28 May / 11June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’… [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
4 Sep 2022, 4:15 pm by INFORRM
The Clearing House is where the Cabinet Office oversees and advises on certain FOI requests received by other Government departments. [read post]
13 Oct 2008, 12:12 pm
(IPKat) German Federal Supreme Court (Bundesgerichtshof) guidance regarding registrability of 'spa' in relation to beauty care products and spa services (Class 46)   Europe ARMAFOAM: the ECJ rules on linguistic and changes OHIM's rules on conversion: Armacell v OHIM (CATCH US IF YOU CAN !!!) [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]